Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anthisan
2. Boots Bite And Sting Relief
3. Kriptin
4. Maleate, Mepyramine
5. Maleate, Pyrilamine
6. Mepyramine
7. Mepyramine Maleate
8. Pyranisamine
9. Pyrilamine
1. Mepyramine Maleate
2. 59-33-6
3. Histatex
4. Histan
5. Anisopyradamine
6. Histosol
7. Minihist
8. Pyrilamine Maleate Salt
9. Diaminide Maleate
10. Paraminyl Maleate
11. Antihist
12. Enrumay
13. Histine
14. Paramal
15. Pymafed
16. Pyraninyl
17. Renstamin
18. Pyramal Maleate
19. Stangen Maleate
20. Anthisan Maleate
21. Statomin Maleate
22. Thylogen Maleate
23. Pyra-maleate
24. Neoantergan Maleate
25. Pyranilamine Maleate
26. Pyranisamine Maleate
27. Neo-antergan Maleate
28. 2786 R.p. Maleate
29. Stamine
30. Neo-antergan
31. Nsc-3604
32. 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)pyridine Maleate (1:1)
33. Mls000069668
34. R35d29l3za
35. 1,2-ethanediamine, N-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-, (z)-2-butenedioate (1:1)
36. Kriptin Maleate
37. Pyra Maleate
38. Prefrin A
39. Dorantamin Maleate
40. (z)-but-2-enedioic Acid;n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine
41. 1,2-ethanediamine,n-[(4-methoxyphenyl)methyl]-n',n'-dimethyl-n-2-pyridinyl-,(2z)-2-butenedioate (1:1)
42. Smr000058495
43. Histavet-p (veterinary)
44. (e)-but-2-enedioic Acid;n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine
45. N,n-dimethyl-n'-{[4-(methyloxy)phenyl]methyl}-n'-pyridin-2-ylethane-1,2-diamine (2z)-but-2-enedioate
46. Mepyramine Hydrogen Maleinate
47. Pyma
48. Histavet-p
49. Mepiramine Maleate
50. N1-(4-methoxybenzyl)-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diamine Maleate
51. Component Of Pyrdex
52. Pymafed (tn)
53. Ccris 1330
54. Cas-59-33-6
55. Sr-01000000225
56. Nsc 3604
57. Einecs 200-422-7
58. Mfcd00069333
59. Pyrilamine Maleate (usp)
60. Component Of Endotussin-nn
61. Unii-r35d29l3za
62. N-dimethylaminoethyl-n-p-methoxy-alpha-aminopyridine Maleate
63. Pyrilamine Maleate [usan:usp]
64. N,n-dimethyl-n'-(4-methoxybenzyl)-n'-(2-pyridyl)ethylenediamine Maleate
65. N-p-methoxybenzyl-n',n'-dimethyl-n-alpha-pyridylethylenediamine Maleate
66. Prestwick_634
67. Opera_id_1702
68. 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine Bimaleate
69. Dsstox_cid_1216
70. P 5514
71. Pyridine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)-, Maleate (1:1)
72. Dsstox_rid_76015
73. Dsstox_gsid_21216
74. Schembl27430
75. 1,2-ethanediamine, N-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-, (2z)-2-butenedioate (1:1)
76. Mls001148634
77. Pyrilamine Maleate; Mepyramine
78. Spectrum1500519
79. Pyrilamine Maleate [mi]
80. Chembl1201006
81. Dtxsid4021216
82. Hms500i17
83. Nsc3604
84. Hms1568j20
85. Hms1920n10
86. Hms2092e11
87. Hms2095j20
88. Hms2234i23
89. Hms2234i24
90. Hms3262b22
91. Hms3411m20
92. Hms3675m20
93. Hms3712j20
94. Pharmakon1600-01500519
95. Pyrilamine Maleate [vandf]
96. Mepyramine Maleate [mart.]
97. Hy-b1281
98. Mepyramine Maleate [who-dd]
99. Pyrilamine Maleate [usp-rs]
100. Tox21_200514
101. Tox21_500890
102. 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine Maleate
103. Ccg-39244
104. N-(dimethylamino)ethyl-n-(p-methoxy)-.alpha.-aminopyridine Maleate
105. Nsc757305
106. S4382
107. Akos015950805
108. N-(p-methoxybenzyl)-n',n'-dimethyl-n-.alpha.-pyridylethylenediamine Maleate
109. Lp00890
110. Nsc-757305
111. Pyrilamine Maleate [green Book]
112. Pyrilamine Maleate [orange Book]
113. Mepyramine Maleate [ep Monograph]
114. Ncgc00094209-01
115. Ncgc00094209-02
116. Ncgc00094209-03
117. Ncgc00094209-04
118. Ncgc00094209-05
119. Ncgc00258068-01
120. Ncgc00261575-01
121. 1,2-ethanediamine, N1-((4-methoxyphenyl)methyl)-n2,n2-dimethyl-n1-2-pyridinyl-, (2z)-2-butenedioate (1:1)
122. Pyrilamine Maleate [usp Monograph]
123. Smr000653462
124. B6396
125. Cs-0013057
126. Eu-0100890
127. P2369
128. Prefrin-a Component Pyrilamine Maleate
129. D05660
130. Pyrilamine Maleate Component Of Prefrin-a
131. Wln: T6nj Bn1r Do1&2n1&1 &ov1u1vo
132. Sr-01000000225-2
133. Sr-01000000225-4
134. Sr-01000000225-5
135. Sr-01000000225-8
136. Q27287732
137. N-(p-methoxybenzyl)-n,2-ethanediamine, Maleic Acid Salt
138. 2-[(2-dimethylaminoethyl)(p-methoxybenzyl)amino]pyridine Maleate
139. Mepyramine Maleate, European Pharmacopoeia (ep) Reference Standard
140. 2-[[2-(dimethylamino)ethyl]( P-methoxybenzyl)amino]pyridine Maleate (1:1)
141. Pyrilamine Maleate, United States Pharmacopeia (usp) Reference Standard
142. 1, N-[(4-methoxyphenyl)methyl]-n',n'-dimethyl-n-2-pyridinyl-, (z)-2-butenedioate (1:1)
143. N-(4-methoxyphenyl)methyl-n',n'-dimethyl-n-(2-pyridinyl)-1,2-ethanediamine Maleate
144. N1-(4-methoxybenzyl)-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diaminemaleate
145. Pyrilamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
146. N-(4-methoxybenzyl)-n',n'-dimethyl-n-pyridin-2-ylethane-1,2-diamine (2z)-but-2-enedioate
Molecular Weight | 401.5 g/mol |
---|---|
Molecular Formula | C21H27N3O5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 401.19507097 g/mol |
Monoisotopic Mass | 401.19507097 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 396 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Sleep Aids, Pharmaceutical
Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS. (See all compounds classified as Sleep Aids, Pharmaceutical.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Coughcod Senior
Dosage Form : SYR
Dosage Strength : 12.5mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Coughcod Senior
Dosage Form : SYR
Dosage Strength : 12.5mg/5ml
Packaging : 200X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Coughcod Junior
Dosage Form : SYR
Dosage Strength : 5mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Histodor
Dosage Form : TAB
Dosage Strength : 25mg
Packaging : 1000X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Histodor
Dosage Form : CRE
Dosage Strength : 50mg/5g
Packaging : 20X1mg/5g
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Vidol
Dosage Form : POW
Dosage Strength : 5mg
Packaging : 1X10mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Vidol
Dosage Form : POW
Dosage Strength : 5mg
Packaging : 1X20mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Vidol
Dosage Form : POW
Dosage Strength : 5mg
Packaging : 1X30mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Docsed
Dosage Form : SYR
Dosage Strength : 20mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Docsed
Dosage Form : SYR
Dosage Strength : 20mg/5ml
Packaging : 200X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Pyrilamine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyrilamine Maleate manufacturer or Pyrilamine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyrilamine Maleate manufacturer or Pyrilamine Maleate supplier.
PharmaCompass also assists you with knowing the Pyrilamine Maleate API Price utilized in the formulation of products. Pyrilamine Maleate API Price is not always fixed or binding as the Pyrilamine Maleate Price is obtained through a variety of data sources. The Pyrilamine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Stangen maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stangen maleate, including repackagers and relabelers. The FDA regulates Stangen maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stangen maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Stangen maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Stangen maleate supplier is an individual or a company that provides Stangen maleate active pharmaceutical ingredient (API) or Stangen maleate finished formulations upon request. The Stangen maleate suppliers may include Stangen maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Stangen maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Stangen maleate DMF (Drug Master File) is a document detailing the whole manufacturing process of Stangen maleate active pharmaceutical ingredient (API) in detail. Different forms of Stangen maleate DMFs exist exist since differing nations have different regulations, such as Stangen maleate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Stangen maleate DMF submitted to regulatory agencies in the US is known as a USDMF. Stangen maleate USDMF includes data on Stangen maleate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stangen maleate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Stangen maleate suppliers with USDMF on PharmaCompass.
A Stangen maleate CEP of the European Pharmacopoeia monograph is often referred to as a Stangen maleate Certificate of Suitability (COS). The purpose of a Stangen maleate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Stangen maleate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Stangen maleate to their clients by showing that a Stangen maleate CEP has been issued for it. The manufacturer submits a Stangen maleate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Stangen maleate CEP holder for the record. Additionally, the data presented in the Stangen maleate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Stangen maleate DMF.
A Stangen maleate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Stangen maleate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Stangen maleate suppliers with CEP (COS) on PharmaCompass.
A Stangen maleate written confirmation (Stangen maleate WC) is an official document issued by a regulatory agency to a Stangen maleate manufacturer, verifying that the manufacturing facility of a Stangen maleate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Stangen maleate APIs or Stangen maleate finished pharmaceutical products to another nation, regulatory agencies frequently require a Stangen maleate WC (written confirmation) as part of the regulatory process.
click here to find a list of Stangen maleate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stangen maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Stangen maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Stangen maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Stangen maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stangen maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Stangen maleate suppliers with NDC on PharmaCompass.
Stangen maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Stangen maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Stangen maleate GMP manufacturer or Stangen maleate GMP API supplier for your needs.
A Stangen maleate CoA (Certificate of Analysis) is a formal document that attests to Stangen maleate's compliance with Stangen maleate specifications and serves as a tool for batch-level quality control.
Stangen maleate CoA mostly includes findings from lab analyses of a specific batch. For each Stangen maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Stangen maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Stangen maleate EP), Stangen maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stangen maleate USP).